Orchard Therapeutics Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	119.22	22.48	12.93	4.2
Short-Term Investments	7.27	5.84	4.42	3.66
Cash & Short-Term Investments	126.48	28.32	17.35	7.85
Cash Growth	346.64%	63.20%	120.96%	-
Accounts Receivable	26.29	32.47	29.89	26.44
Other Receivables	0.1	5.18	17.67	24.75
Receivables	26.39	37.66	47.56	51.19
Inventory	26.54	38.02	31.63	27.13
Prepaid Expenses	18.06	8.06	5.07	5.32
Other Current Assets	-	-	0.12	0.05
Total Current Assets	197.47	112.05	101.72	91.55
Property, Plant & Equipment	39.45	28.24	21.96	22.37
Long-Term Deferred Tax Assets	1.88	0.77	0.43	0.15
Other Long-Term Assets	3.2	-	-	-
Total Assets	242	141.05	124.11	114.07
Accounts Payable	17.26	12.74	2.93	3.57
Short-Term Debt	-	-	0.2	1.57
Current Portion of Long-Term Debt	-	6.47	10.47	15.37
Current Portion of Leases	16.82	12.57	9.65	8.09
Current Income Taxes Payable	0.7	4.63	6.82	7.41
Current Unearned Revenue	2.77	2.26	1.64	1.13
Other Current Liabilities	-	0.72	13.11	15.07
Total Current Liabilities	37.54	39.39	44.82	52.2
Long-Term Leases	15.4	9.94	8.13	9.66
Long-Term Deferred Tax Liabilities	-	0.01	0.01	-
Other Long-Term Liabilities	1.88	1.08	1.05	0.59
Total Liabilities	54.82	50.42	54.02	62.46
Common Stock	1.33	1.51	1.51	1.51
Retained Earnings	185.85	89.12	68.58	50.11
Shareholders' Equity	187.18	90.63	70.09	51.62
Total Liabilities & Equity	242	141.05	124.11	114.07
Total Debt	32.22	28.98	28.44	34.69
Net Cash (Debt)	94.27	-0.66	-11.09	-26.84
Net Cash Per Share	0.93	-0.01	-	-
Filing Date Shares Outstanding	133.33	133.33	-	-
Total Common Shares Outstanding	133.33	133.33	-	-
Working Capital	159.93	72.66	56.9	39.34
Book Value Per Share	1.40	0.68	-	-
Tangible Book Value	187.18	90.63	70.09	51.62
Tangible Book Value Per Share	1.40	0.68	-	-
Machinery	8.26	7.57	6.39	5.72
Leasehold Improvements	15.33	10.55	7.03	5.51

Source: S&P Global Market Intelligence. Standard template. Financial Sources.